+971.7%
MRNA vs IOVA
-26.1%
+997.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | IOVA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -2.3% | +3.6% | +1.8% |
| 7D | -13.8% | -4.2% | -9.6% | -13.0% |
| 30D | -17.7% | -50.8% | +33.1% | -5.8% |
| 3M | +14.3% | -8.5% | +22.8% | +11.3% |
| 6M | +336.0% | +111.3% | +224.7% | +252.6% |
| YTD | +575.9% | +167.8% | +408.2% | +407.0% |
| 1Y | +724.4% | +223.5% | +500.9% | +493.4% |
| 3Y | +160.8% | +44.8% | +116.0% | +91.0% |
| 5Y | -24.4% | -61.2% | +36.7% | -37.5% |
| All | +971.7% | -26.1% | +997.8% | +590.0% |
Cumulative growth
Daily Returns
Daily percentage return beside IOVA.
Daily Out/Under-Performance
Portfolio return minus IOVA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IOVA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded IOVA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling